Prospective randomized trial of corneal cross-linking riboflavin dosing frequencies for treatment of keratoconus and corneal ectasia
Ophthalmology Dec 07, 2017
Price MO, et al. - The goal of this paper was to determine if the riboflavin dosing frequency exerted an impact on the corneal cross-linking efficacy or safety, given that isotonic riboflavin solution was viscous and each installation coated the corneal surface with a film that absorbed some of the incident ultraviolet A light. An equivalent reduction was yielded in the maximum keratometry value due to the 2 riboflavin dosing regimens, exhibiting a favorable safety profile.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries